Bio-Synthesis, Inc. offers genomic and proteomic research products and services for life science research, cell line validation, diagnostics, and therapeutic applications. Its solutions include oligonucleotide, peptides, and antibodies; and DNA and peptide synthesis, organic and oligo synthesis, bioconjugations, molecular diagnostic detection kits, DNA real-time PCR products, DNA microarray services, and a range of DNA-based diagnostic kits and consumables. The company also provides peptides, carrier conjugation, anti-peptide antibodies, and antigenic peptides; detection and analytical services, such as sequencing, amino acid analysis, mass spectrometry, HLA typing, PCR-SSP based assay development, DNA/peptide based assay development, elisa based Ag/Ab assay development, cell authentication, and DNA testing and analysis services; and informatics solutions by combining Web-lab and in silico approaches to life science and healthcare sectors. In addition, the firm provides contract manufacturing and consultation services, including research, development, and production services for cGMP clinical batch manufacturing.
